Dementia causes the brain to physically shrink, lose connections between nerve cells, and eventually suffer widespread cell death. While a healthy brain loses about 0.4% of its volume per year with normal aging, a brain with Alzheimer’s disease loses 0.6% to 1.4% per year, depending on severity. These changes don’t happen all at once. They follow a pattern that starts years before symptoms appear, beginning in specific regions and gradually spreading outward.
Where the Damage Starts
In Alzheimer’s disease, the most common form of dementia, the destruction begins in a small region called the entorhinal cortex, which sits just next to the hippocampus, the brain’s memory center. This is where toxic protein deposits first appear. From there, the damage spreads into the hippocampus itself, then outward to the temporal cortex, the frontoparietal cortex, and deeper brain structures.
This progression explains why memory problems are usually the first symptom. The hippocampus is responsible for forming new episodic memories, the kind that let you recall what you had for breakfast or where you parked the car. As the hippocampus shrinks, short-term memory deteriorates. Over time, as damage reaches other brain regions, problems with language, spatial awareness, judgment, and personality follow.
Toxic Proteins That Spread Like a Chain Reaction
The hallmark of Alzheimer’s is the buildup of two abnormal proteins. The first, beta-amyloid, clumps together into plaques that collect between nerve cells and disrupt their function. The second, tau, normally helps maintain the internal transport system that moves nutrients through each neuron. In Alzheimer’s, tau detaches from that scaffolding, sticks to other tau molecules, and forms tangles inside the cells. These tangles block the neuron’s transport system and eventually kill it.
Once misfolded, these proteins recruit healthy neighboring proteins into the same dysfunctional shape. It’s a cascade: as beta-amyloid reaches a tipping point, tau spreads rapidly throughout the brain. This is why the disease accelerates. What begins as subtle forgetfulness progresses to confusion, then to the inability to carry out daily tasks, as more and more brain regions are overtaken.
Not all dementias involve the same proteins. In Lewy body dementia, a different protein called alpha-synuclein aggregates inside neurons, forming clumps known as Lewy bodies. These deposits appear in the same brains affected by Parkinson’s disease and cause a distinctive mix of cognitive problems, visual hallucinations, and movement difficulties.
How Nerve Cells Lose the Ability to Communicate
Before neurons die, they lose their ability to talk to each other. The connections between brain cells, called synapses, are among the first casualties. In a healthy aging brain, the tiny spines that receive signals from neighboring neurons decrease by nearly 50%, and the branching structures that extend from each cell shrink by about 9% to 11%. Dementia accelerates this process dramatically.
Synaptic loss is one of the strongest predictors of cognitive decline. Brain functions depend on constant communication between distant regions. When those connections break down, entire networks go offline. A person might still have neurons in the language centers of the brain, for example, but if those cells can’t coordinate with memory and motor regions, speech becomes fragmented or impossible.
The Chemical Shortfall
As neurons degenerate, the brain loses its ability to produce key chemical messengers. The most significant drop is in a signaling chemical that supports memory, attention, and learning. Cells deep in the base of the brain that produce this messenger are especially vulnerable to Alzheimer’s, and their loss has been documented extensively in early-onset cases and advanced late-onset disease. Beta-amyloid appears to directly interfere with the receptors these cells rely on, creating a vicious cycle: the toxic protein both kills the cells and disrupts the chemical signals they were trying to send.
This chemical deficit is one reason current medications for Alzheimer’s exist. They work by slowing the breakdown of the remaining chemical messenger, squeezing more function out of the neurons that are still alive. They don’t stop the disease, but they can temporarily ease symptoms.
The Brain’s Immune System Turns Destructive
The brain has its own immune cells, and in dementia, they become part of the problem. When these cells first detect amyloid plaques, they respond appropriately, attempting to clear the debris. But prolonged activation changes their behavior. Instead of cleaning up, they begin releasing inflammatory molecules that damage neurons, break down the brain’s protective blood barrier, and allow additional immune cells to flood in from the bloodstream.
This chronic inflammation is now recognized as a core feature of Alzheimer’s, not just a side effect. As the disease worsens, these immune cells lose their ability to clear amyloid effectively while continuing to pump out toxic compounds. The result is a feedback loop: more inflammation leads to more plaque buildup, which triggers more inflammation, which accelerates neuron death and synapse loss.
Vascular Dementia: A Different Path to the Same Destination
Not all dementia is driven by toxic proteins. Vascular dementia results from conditions that reduce blood flow and oxygen to the brain. Small vessel disease narrows and hardens the tiny blood vessels that feed deep brain tissue. Over time, this starves white matter, the wiring that connects different brain regions, of the oxygen and nutrients it needs.
The damage shows up on brain scans as white patches scattered through the brain’s interior. In some cases, small strokes kill pockets of tissue outright, leaving areas of dead cells. In others, a condition involving thickened and narrowed blood vessels gradually chokes off supply to white matter, degrading the brain’s communication pathways. The cognitive effects depend on where the damage lands: blood flow problems near the frontal lobes tend to affect planning and decision-making, while damage in other areas may impair movement or speech.
What the Brain Looks Like in Late Stages
By the final stages of any progressive dementia, the physical changes are visible to the naked eye. The brain has lost significant volume. The grooves on its surface, normally narrow, have widened dramatically. The fluid-filled chambers in the center of the brain, called ventricles, have expanded to fill the space left by dead tissue. The cortex, the wrinkled outer layer responsible for thought, language, and perception, has thinned considerably.
This widespread shrinkage reflects massive cell death across nearly every brain region. The person at this stage has lost the neural infrastructure for memory, language, movement, and eventually the basic functions that sustain life, such as swallowing and breathing. The progression from earliest changes to this point typically spans years to over a decade, depending on the type of dementia and individual factors.
The Scale of the Problem
An estimated 57.4 million people worldwide were living with dementia in 2019. Projections based on the Global Burden of Disease Study suggest that number will climb to roughly 153 million by 2050. The increases will not be evenly distributed: western Europe and high-income parts of Asia are projected to see 53% to 74% growth, while regions in north Africa, the Middle East, and sub-Saharan Africa face increases exceeding 350%, driven largely by aging populations and shifting risk factor profiles.